Not admitted · Not a forecast
Rules 1.1.0 · as of 14 Sep 2026
Owen Scott Muir · Said 18 Mar 2023 · owen-0368
Quote
Not a forecast
“Neuronetics presents such an opportunity.”
Post arguing healthcare is full of arbitrage. Neuronetics (TMS device maker, market cap about $149m at the post date) charges a per-treatment fee although the figure-8 coil is not patented and MagStim, MagVenture, cloud TMS and others sell near-identical devices. The author says Neuronetics presents an arbitrage opportunity, i.e. a bet (via puts) that its share price falls.
Descriptive, retrospective, or a statement of preference; no future state asserted.